{
    "nct_id": "NCT06222437",
    "official_title": "Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy",
    "inclusion_criteria": "* Age 18-45\n* Body mass index(BMI) > 30\n* Diagnosis of PCOS\n* Normal thyroid stimulating hormone, prolactin, follicle-stimulating hormone (FSH), estradiol, and normal progesterone\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 45 Years",
    "exclusion_criteria": "* Medications excluded: any hormone-containing contraceptive - oral contraceptive pills, Progesterone-only pill, depo-provera, oral provera, progesterone-containing intrauterine contraceptive device\n* Letrozole, clomiphene citrate, FSH therapy\n* Androgen receptor blockers\n* 5Î± reductase inhibitors\n* Insulin\n* Hysterectomy\n* Endometrial ablation",
    "miscellaneous_criteria": ""
}